Raymond James & Associates Sells 4,681 Shares of Xylem Inc. (NYSE:XYL)

Raymond James & Associates reduced its holdings in Xylem Inc. (NYSE:XYLGet Rating) by 4.9% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 89,956 shares of the industrial products company’s stock after selling 4,681 shares during the quarter. Raymond James & Associates’ holdings in Xylem were worth $7,860,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the business. Clarius Group LLC bought a new position in shares of Xylem in the 3rd quarter worth approximately $248,000. Xponance Inc. boosted its position in shares of Xylem by 11.7% during the third quarter. Xponance Inc. now owns 24,196 shares of the industrial products company’s stock valued at $2,114,000 after buying an additional 2,532 shares during the period. Thrive Wealth Management LLC boosted its position in shares of Xylem by 28.3% during the third quarter. Thrive Wealth Management LLC now owns 5,341 shares of the industrial products company’s stock valued at $467,000 after buying an additional 1,179 shares during the period. State of Michigan Retirement System boosted its position in shares of Xylem by 0.4% during the third quarter. State of Michigan Retirement System now owns 48,775 shares of the industrial products company’s stock valued at $4,261,000 after buying an additional 200 shares during the period. Finally, Miracle Mile Advisors LLC purchased a new stake in shares of Xylem in the third quarter valued at approximately $704,000. 83.57% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, SVP Matthew Francis Pine sold 11,870 shares of the company’s stock in a transaction on Friday, November 4th. The shares were sold at an average price of $107.12, for a total value of $1,271,514.40. Following the sale, the senior vice president now directly owns 22,819 shares of the company’s stock, valued at approximately $2,444,371.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.89% of the stock is currently owned by insiders.

Xylem Stock Performance

Shares of XYL stock opened at $116.93 on Friday. The business’s fifty day simple moving average is $111.37 and its 200-day simple moving average is $98.41. The company has a market cap of $21.07 billion, a PE ratio of 66.44, a PEG ratio of 2.91 and a beta of 1.09. The company has a current ratio of 1.65, a quick ratio of 1.22 and a debt-to-equity ratio of 0.58. Xylem Inc. has a 12-month low of $72.08 and a 12-month high of $118.58.

Xylem (NYSE:XYLGet Rating) last issued its earnings results on Tuesday, November 1st. The industrial products company reported $0.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.66 by $0.13. The company had revenue of $1.38 billion during the quarter, compared to analyst estimates of $1.33 billion. Xylem had a return on equity of 14.40% and a net margin of 5.97%. Analysts expect that Xylem Inc. will post 2.71 earnings per share for the current fiscal year.

Xylem Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 20th. Investors of record on Tuesday, November 22nd were issued a $0.30 dividend. The ex-dividend date was Monday, November 21st. This represents a $1.20 annualized dividend and a yield of 1.03%. Xylem’s dividend payout ratio (DPR) is presently 68.18%.

Wall Street Analysts Forecast Growth

XYL has been the subject of a number of research reports. The Goldman Sachs Group boosted their price target on Xylem from $85.00 to $95.00 and gave the company a “neutral” rating in a report on Thursday, November 3rd. Royal Bank of Canada boosted their price target on Xylem from $105.00 to $114.00 and gave the company an “outperform” rating in a report on Wednesday, November 2nd. Morgan Stanley boosted their price objective on shares of Xylem from $100.00 to $105.00 and gave the stock an “overweight” rating in a research note on Thursday, November 3rd. Atlantic Securities raised shares of Xylem from a “neutral” rating to an “overweight” rating and boosted their price objective for the stock from $110.00 to $129.00 in a research note on Wednesday, November 16th. Finally, Credit Suisse Group boosted their price objective on shares of Xylem from $93.00 to $110.00 and gave the stock a “neutral” rating in a research note on Wednesday, November 2nd. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $112.60.

Xylem Company Profile

(Get Rating)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications in the United States, Europe, the Asia Pacific, and internationally. It operates through three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions.

See Also

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.